AIDAN raises concerns over NPPA chairman's transfer

Demands that the NPPA be made into a statutory body to ensure the independence and integrity of the regulator

xffxcvxvx

Pratap Vikram Singh | March 1, 2018 | New Delhi


#AIDAN   #NPPA   #All India Drug Action Network   #National Pharmaceutical Pricing Authority  

All India Drug Action Network (AIDAN) has accused US-based multinational firms in healthcare for running a malicious campaign against National Pharmaceutical Pricing Authority (NPPA) and the transfer of its chairman Bhupendra Singh. The government move would adversely impact the NPPA's ongoing work against unethical profiteering by pharmaceutical companies, device makers and corporate hospitals, the AIDAN said in a statement.

According to a government notification issued on Wednesday, the appointments committee of the cabinet has transferred Singh to National Authority for Chemical Weapons Convention in the rank and pay of additional secretary.

"The NPPA under the governance of Injeti Srinivas (former chairman) and Singh showered tremendous leadership. Srinivas was transferred even before the completion of one year following the price regulation of critical cardiac and diabetes medicines through public interest of the DPCO. During his term, Singh has taken many positive steps to ensure affordability of medicines and medical devices that discomforted the industry," the AIDAN, a non-governmental organisation working towards increasing access and rational use of essential medicines, said. 

Notably, the NPPA undertook landmark price control of stents and knee implants. There was greater accountability to the public because of increased transparency and responsiveness to grievances of patients and the industry.

The NPPA, the AIDAN said, also saw unprecedented success in the courts with its stands vindicated by favourable judgments passed by the supreme court and high courts in most cases.

Of late, the NPPA took a proactive role in initiating monitoring of high margins charged by private hospitals in an effort to curb unethical profiteering.

"We fear that Singh's transfer in total disregard to the public interest is due to the pressure from the industry and corporate hospital lobby," the AIDAN said.

The pharmaceutical industry has long sought to undermine and weaken the NPPA in order to enable uninhibited profiteering and circumvention of the law. The recent price revise of coronary stents angered the US-based MNCs which ran a malicious campaign against the regulatory authority, the AIDAN said. 

"The final precipitating factor, we believe, was the report analysing bills of four patients and which exposed the gross overcharging and misconduct of private hospitals. In this same report, the NPPA appealed for policy intervention to correct the injustice towards patients as it had reached the limits of its mandate," the non-governmental organisation said.  

The AIDAN urged the government to reconsider its decision and allow Singh to complete his three year term at the NPPA. It also demanded that the NPPA be made into a statutory body along with fixed term periods for the chairman and leadership to ensure the independence and integrity of the regulator.

Comments

 

Other News

Sustainable travel emerging as preferred choice: Report

An increasing number of people will prefer to rely on emerging and new technologies and travel in more sustainable ways, according to a global research study, Traveller Tribes 2033, has revealed.   The global survey is third in a series launched in 2007 and identifies four Traveller Trib

Budget creates the ground – now it’s time for these steps

On February 1, finance minister Nirmala Sitharaman announced the Union Budget. As Dr. Rajiv Kumar, the Pahle India Foundation chairman and former NITI Aayog vice chairman, succinctly summed up, “Budget 2023 is a consolidation of the gains over the years, and a positive step towards sustained economic

Should India look for another capital?

The Indian Metropolis: Deconstructing India’s Urban Spaces By Feroze Varun Gandhi Rupa, 840 pages, Rs 1,500 Feroze Varun Gandhi, a Member of Parliament from the BJP, has been a published poet. He is also a policy expert – he had published &

Railways’ freight earnings up by 16%

On mission mode, Indian Railways` Freight loading for first ten months of this financial year 2022-23 has crossed last year’s loading and earnings for the same month. On cumulative basis from April 2022 to January 2023, freight loading of 1243.46 MT was achieved against last year&rsquo

BMC announces Rs 52,619.07 crore budget

Mumbai’s municipal commissioner and administrator Iqbal Singh Chahal on Saturday announced a Budget of Rs 52,619.07 crore for 2023-2024, an increase of 20.67% over a revised budget estimate of Rs 43607.10 crore for 2022-23. The overall budget size has doubled in five years. In 2017-18

Making sense of the ‘crisis of political representation’

Imprints of the Populist Time By Ranabir Samaddar Orient BlackSwan, 352 pages, Rs. 1105 The crisis of liberal democracy in the neoliberal world—marked by massive l

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter